General MedicationsORALStandard

METHYLERGONOVINE MALEATE

Standard Dose

0.2MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview METHYLERGONOVINE MALEATE is listed in Drugs@FDA under application 212233 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient METHYLERGONOVINE MALEATE Form and strength TABLET;ORAL - 0.2MG Sponsor TP ANDA HOLDINGS Submission history Latest submission status date: 2020-05-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview METHYLERGONOVINE MALEATE is listed in Drugs@FDA under application 212233 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient METHYLERGONOVINE MALEATE Form and strength TABLET;ORAL - 0.2MG Sponsor TP ANDA HOLDINGS Submission history Latest submission status date: 2020-05-01 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.